Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Pazaiti A"'
Autor:
Zagouri Flora, Sergentanis Theodoros, Nonni Afrodite, Papadimitriou Christos, Pazaiti Anastasia, Michalopoulos Nikolaos V, Safioleas Panagiotis, Lazaris Andreas, Theodoropoulos George, Patsouris Effstratios, Zografos George
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 409 (2010)
Abstract Background Elevated Hsp90 expression has been documented in breast ductal carcinomas, whereas decreased Hsp90 expression has been reported in precursor lobular lesions. This study aims to assess Hsp90 expression in infiltrative lobular carci
Externí odkaz:
https://doaj.org/article/19a77d2acaf8479cb194c137abb25a4c
Autor:
Patsouris Effstratios, Lazaris Andreas, Theodoropoulos George, Domeyer Philip, Michalopoulos Nikolaos V, Papadimitriou Christos A, Nonni Afrodite, Sergentanis Theodoros N, Zagouri Flora, Zogafos Eleni, Pazaiti Anastazia, Zografos George C
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 353 (2010)
Abstract Background Hsp90 (heat shock protein90) is a chaperone protein essential for preserving and regulating the function of various cellular proteins. Elevated Hsp90 expression seems to be a trait of breast cancer and may be an integral part of t
Externí odkaz:
https://doaj.org/article/6a9521a175494b7d88a4eef2e4b07162
Autor:
Papadimitriou, Marios C., Pazaiti, Anastasia, Iliakopoulos, Konstantinos, Markouli, Mariam, Michalaki, Vasiliki, Papadimitriou, Christos A.
Publikováno v:
In BBA - Molecular Cell Research December 2022 1869(12)
Autor:
Marios C, Papadimitriou, Anastasia, Pazaiti, Konstantinos, Iliakopoulos, Mariam, Markouli, Vasiliki, Michalaki, Christos A, Papadimitriou
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869:119346
Selective CDK4/6 inhibitors, such as palbociclib, ribociclib, and abemaciclib, have been approved in combination with hormone therapy for the treatment of patients with HR+, HER2-negative advanced or metastatic breast cancer (mBC). Despite their prom
Autor:
Dimitrios T. Trafalis, Athanasios Tampakis, Anastasia Pazaiti, Constantinos Alifieris, Michalis Kontos, Dimitrios Krikelis, Ekaterini Christina Tampaki
Publikováno v:
Clinical Drug Investigation. 38:639-648
In the era of personalized therapy, targeted treatment in specific patient populations is mandated. We evaluated the efficacy and safety of neoadjuvant treatment on locally advanced breast cancer (LABC) with a monoclonal agent against vascular endoth
Autor:
Anastasia Pazaiti, Ian S. Fentiman
Publikováno v:
International Journal of Breast Cancer, Vol 2011 (2011)
Sentinel lymph node biopsy (SLNB) is a safe and accurate minimally invasive method for detecting axillary lymph node (ALN) involvement in the clinically negative axilla thereby reducing morbidity in patients who avoid unnecessary axillary lymph node
Externí odkaz:
https://doaj.org/article/f0fc252bc9ac421a93204e6ed3073636
Autor:
Nikolaos V. Michalopoulos, W. Al-Harethee, Vasileios Kalles, Evangelos Menenakos, Afroditi Nonni, Georgios E. Theodoropoulos, Maria Matiatou, Dimitra Koulocheri, Georgios Zografos, P. Liakou, Anastasia Pazaiti, Georgia Georgiou, Ioannis Papapanagiotou
Publikováno v:
Breast Cancer. 25:134-140
The Breast Lesion Excision System® (BLES®) is a stereotactic vacuum-assisted breast biopsy device that utilizes radiofrequency in order to excise non-palpable mammographic lesions for pathologic diagnosis. The purpose of this study was to evaluate
Autor:
Spandou, Evangelia, Papadopoulou, Zoi, Soubasi, Vassiliki, Karkavelas, George, Simeonidou, Constantina, Pazaiti, Anastasia, Guiba-Tziampiri, Olympia
Publikováno v:
In Brain Research 2005 1045(1):22-30
Background: The Breast Lesion Excision System® (BLES®) is a stereotactic vacuum-assisted breast biopsy device that utilizes radiofrequency in order to excise non-palpable mammographic lesions for pathologic diagnosis. The purpose of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::954bc4efcf784668ed149111dc208a5f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123648
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123648
Autor:
Tampaki, E.C. Tampakis, A. Alifieris, C.E. Krikelis, D. Pazaiti, A. Kontos, M. Trafalis, D.T.
Background: In the era of personalized therapy, targeted treatment in specific patient populations is mandated. Objective: We evaluated the efficacy and safety of neoadjuvant treatment on locally advanced breast cancer (LABC) with a monoclonal agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b87b7cda3a15b3bb4b2bbc4010dc9996
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123250
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123250